A Case Series of Proton Pump Inhibitor-Induced Hypomagnesemia

American Journal of Kidney Diseases

Volumn 56, Issue 1, 2010, Pages 112-116

  Hoorn, Ewout J ^a   van der Hoek, Joost ^a   de Man, Rob A ^a   Kuipers, Ernst J ^a   Bolwerk, Clemens ^b   Zietse, Robert ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b Reinier de Graaf Gasthuis Delft ^*  (Netherlands)

Author keywords

Adverse drug reaction; arrhythmia; hypocalcemia; hypokalemia

Indexed keywords

ACETYLSALICYLIC ACID; AMLODIPINE; ANTIBIOTIC AGENT; ATENOLOL; ATORVASTATIN; BISOPROLOL; CALCIUM; CALCIUM DERIVATIVE; COUMARIN DERIVATIVE; ESOMEPRAZOLE; FAMOTIDINE; GASTROINTESTINAL AGENT; GASTROZIPIN; LISINOPRIL; MAGNESIUM; MAGNESIUM DERIVATIVE; METFORMIN; OMEPRAZOLE; PANTOPRAZOLE; PARATHYROID HORMONE; POTASSIUM; PREDNISONE; PROTON PUMP INHIBITOR; RABEPRAZOLE; RANITIDINE; SIMVASTATIN; UNCLASSIFIED DRUG;

ADULT; AGED; ANTIBIOTIC THERAPY; ARTICLE; BRAIN DISEASE; CALCIUM BLOOD LEVEL; CALCIUM URINE LEVEL; CASE REPORT; COLLAPSE; DISEASE ASSOCIATION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; ELECTROLYTE DISTURBANCE; FEMALE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEREDITY; HOSPITAL ADMISSION; HUMAN; HYPOCALCEMIA; HYPOKALEMIA; HYPOMAGNESEMIA; HYPOPARATHYROIDISM; KALIURESIS; MAGNESIUM BLOOD LEVEL; MAGNESIUM URINE LEVEL; MALE; PARATHYROID HORMONE BLOOD LEVEL; POSTANOXIC ENCEPHALOPATHY; POTASSIUM BLOOD LEVEL; POTASSIUM EXCRETION; QT PROLONGATION; ST SEGMENT DEPRESSION; TREATMENT DURATION; URINARY EXCRETION; URINARY TRACT INFECTION;

AGED; FEMALE; HUMANS; MAGNESIUM DEFICIENCY; MALE; MIDDLE AGED; PROTON PUMP INHIBITORS;

EID: 77953807102     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2009.11.019     Document Type: Article

References (20)

1. Van Soest E.M., Siersema P.D., Dieleman J.P., Sturkenboom M.C., and Kuipers E.J. Persistence and adherence to proton pump inhibitors in daily clinical practice. Aliment Pharmacol Ther 24 (2006) 377-385
2. Nealis T.B., and Howden C.W. Is there a dark side to long-term proton pump inhibitor therapy?. Am J Ther 15 (2008) 536-542
3. Epstein M., McGrath S., and Law F. Proton-pump inhibitors and hypomagnesemic hypoparathyroidism. N Engl J Med 355 (2006) 1834-1836
4. Cundy T., and Dissanayake A. Severe hypomagnesaemia in long-term users of proton-pump inhibitors. Clin Endocrinol (Oxf) 69 2 (2008) 338-341
5. Kuipers M.T., Thang H.D., and Arntzenius A.B. Hypomagnesaemia due to use of proton pump inhibitors-a review. Neth J Med 67 (2009) 169-172
6. Shabajee N., Lamb E.J., Sturgess I., and Sumathipala R.W. Omeprazole and refractory hypomagnesaemia [abstract]. BMJ 337 (2008) a425
7. Naranjo C.A., Busto U., Sellers E.M., et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther 30 (1981) 239-245
8. M'Koma A.E., Lindquist K., and Liljeqvist L. Biochemical laboratory data in patients before and after restorative proctocolectomy. A study on 83 patients with a follow-up of 36 months. Ann Chir 48 (1994) 525-534
9. Pham P.C., Pham P.M., Pham S.V., Miller J.M., and Pham P.T. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol 2 (2007) 366-373
10. Zimmet P., and Breidahl H.D. Intestinal lymphangiectasia with hypomagnesaemic tetany. Australas Ann Med 17 (1968) 265-269
11. Edwards I.R., and Aronson J.K. Adverse drug reactions: definitions, diagnosis, and management. Lancet 356 (2000) 1255-1259
12. Jeppesen P.B., Staun M., Tjellesen L., and Mortensen P.B. Effect of intravenous ranitidine and omeprazole on intestinal absorption of water, sodium, and macronutrients in patients with intestinal resection. Gut 43 (1998) 763-769
13. Serfaty-Lacrosniere C., Wood R.J., Voytko D., et al. Hypochlorhydria from short-term omeprazole treatment does not inhibit intestinal absorption of calcium, phosphorus, magnesium or zinc from food in humans. J Am Coll Nutr 14 (1995) 364-368
14. Hunfeld N.G., Mathot R.A., Touw D.J., et al. Effect of CYP2C19*2 and *17 mutations on pharmacodynamics and kinetics of proton pump inhibitors in Caucasians. Br J Clin Pharmacol 65 (2008) 752-760
15. Huang C.L., and Kuo E. Mechanism of hypokalemia in magnesium deficiency. J Am Soc Nephrol 18 (2007) 2649-2652
16. Quamme G.A. Recent developments in intestinal magnesium absorption. Curr Opin Gastroenterol 24 (2008) 230-235
17. Furuta T., Shirai N., Takashima M., et al. Effect of genotypic differences in CYP2C19 on cure rates for Helicobacter pylori infection by triple therapy with a proton pump inhibitor, amoxicillin, and clarithromycin. Clin Pharmacol Ther 69 (2001) 158-168
18. Helfant R.H. Hypokalemia and arrhythmias. Am J Med 80 (1986) 13-22
19. Yelamanchi V.P., Molnar J., Ranade V., and Somberg J.C. Influence of electrolyte abnormalities on interlead variability of ventricular repolarization times in 12-lead electrocardiography. Am J Ther 8 (2001) 117-122
20. Kingston M.E., Al-Siba'i M.B., and Skooge W.C. Clinical manifestations of hypomagnesemia. Crit Care Med 14 (1986) 950-954